|
DK178590D0
(da)
|
1990-07-26 |
1990-07-26 |
Novo Nordisk As |
1,4-disubstituerede piperaziner
|
|
PT100905A
(pt)
|
1991-09-30 |
1994-02-28 |
Eisai Co Ltd |
Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
|
|
BR9307570A
(pt)
|
1992-12-02 |
1999-05-25 |
Pfizer |
Diéteres de catecol como inibidores seletivos de pdeiv
|
|
DE4323192A1
(de)
|
1993-07-10 |
1995-01-12 |
Basf Ag |
Verfahren zur Herstellung von Homo- und Copolymerisaten von Alk-1-enen
|
|
DE4325846C1
(de)
|
1993-07-31 |
1995-01-19 |
Herberts Gmbh |
Verwendung von Furan-modifizierten aromatischen Pinakolderivaten als Initiatoren und Furan-modifizierte aromatische Pinakolderivate als solche
|
|
DE4343286A1
(de)
|
1993-12-17 |
1995-06-22 |
Hoechst Ag |
Heteroaromatische Verbindungen und ihre Verwendung in flüssigkristallinen Mischungen
|
|
DE4409501A1
(de)
|
1994-03-19 |
1995-09-21 |
Didier Werke Ag |
Verschleißfutter eines Schachtofens und Stein hierfür
|
|
CA2193725A1
(en)
|
1994-06-24 |
1996-01-04 |
David Cavalla |
Aryl derivative compounds and uses to inhibit phosphodiesterase iv acti vity
|
|
US5789434A
(en)
|
1994-11-15 |
1998-08-04 |
Bayer Corporation |
Derivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitors
|
|
TW332201B
(en)
|
1995-04-06 |
1998-05-21 |
Janssen Pharmaceutica Nv |
1,3-Dihydro-1-(phenylalkyl)-2H-imidazol-2-one derivatives
|
|
TW424087B
(en)
|
1995-04-06 |
2001-03-01 |
Janssen Pharmaceutica Nv |
1,3-dihydro-1-(phenylalkenyl)-2H-imidazol-2-one derivatives
|
|
US6037370A
(en)
|
1995-06-08 |
2000-03-14 |
Vertex Pharmaceuticals Incorporated |
Methods and compositions for stimulating neurite growth
|
|
JP2000503984A
(ja)
|
1996-01-22 |
2000-04-04 |
藤沢薬品工業株式会社 |
チアゾリルベンゾフラン誘導体およびその医薬組成物
|
|
AU4015497A
(en)
|
1996-08-26 |
1998-03-19 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Thiazole derivatives useful as selective inhibitors of pde-iv
|
|
JPH1087543A
(ja)
|
1996-09-17 |
1998-04-07 |
Chisso Corp |
アルコキシベンゼン誘導体、液晶組成物および液晶表示素子
|
|
US6548490B1
(en)
|
1997-10-28 |
2003-04-15 |
Vivus, Inc. |
Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
|
|
WO1999045914A1
(en)
|
1998-03-13 |
1999-09-16 |
Maruho Kabushikikaisha |
Alkyl amine derivative and local anesthetic agent using the same
|
|
GB9807354D0
(en)
|
1998-04-07 |
1998-06-03 |
Glaxo Group Ltd |
Antiviral compound
|
|
SE9804212D0
(sv)
|
1998-12-04 |
1998-12-04 |
Astra Pharma Prod |
Compounds
|
|
HUP0202248A3
(en)
|
1999-03-12 |
2006-06-28 |
Boehringer Ingelheim Pharma |
Compounds useful as anti-inflammatory agents
|
|
US7141593B1
(en)
|
1999-06-04 |
2006-11-28 |
Abbott Laboratories |
Pharmaceutical formulations
|
|
GB9929552D0
(en)
|
1999-12-14 |
2000-02-09 |
Proteus Molecular Design |
Compounds
|
|
US6933304B2
(en)
|
2000-06-15 |
2005-08-23 |
Pharmacia Corporation |
Heteroarylalkanoic acids as integrin receptor antagonists
|
|
US20030032579A1
(en)
|
2001-04-20 |
2003-02-13 |
Pfizer Inc. |
Therapeutic use of selective PDE10 inhibitors
|
|
IL158591A0
(en)
|
2001-05-22 |
2004-05-12 |
Pfizer Prod Inc |
Crystal forms of azithromycin
|
|
AU2003229912A1
(en)
*
|
2002-04-18 |
2003-11-03 |
Avecia Limited |
Prepation of a conjugated molecule and materials for use therein
|
|
US6821502B2
(en)
|
2002-06-12 |
2004-11-23 |
Chevron U.S.A. Inc. |
Method of making aluminum-containing zeolite with IFR structure
|
|
JP2005533858A
(ja)
|
2002-07-27 |
2005-11-10 |
アストラゼネカ アクチボラグ |
化合物
|
|
AU2003275493A1
(en)
|
2002-10-08 |
2004-05-04 |
The Scripps Research Institute |
Inhibitors of fatty acid amide hydrolase
|
|
WO2004041258A2
(fr)
|
2002-10-30 |
2004-05-21 |
Neuro3D |
Utilisation d’inhibiteurs des phosphodiesterases des nucleotides cycliques, ayant une structure benzodiazepinique en therapie
|
|
TW200410921A
(en)
|
2002-11-25 |
2004-07-01 |
Hoffmann La Roche |
Mandelic acid derivatives
|
|
US20060040986A1
(en)
|
2002-12-06 |
2006-02-23 |
Kowa Co., Ltd. |
Erythropoietin production accelerator
|
|
US20050043344A1
(en)
|
2002-12-20 |
2005-02-24 |
Pharmacia Corporation |
Heteroarylalkanoic acids as integrin receptor antagonists derivatives
|
|
WO2004071509A1
(ja)
|
2003-02-12 |
2004-08-26 |
Nippon Chemiphar Co., Ltd. |
オリゴデンドロサイト分化促進剤
|
|
KR20060005375A
(ko)
|
2003-04-18 |
2006-01-17 |
메모리 파마슈티칼스 코포레이션 |
포스포디에스테라제 4 억제제로서의 피라졸 유도체
|
|
AR047541A1
(es)
|
2004-02-13 |
2006-01-25 |
Sandoz Ag |
Fosfato de 5-[[4-[2-metil-2-piridinil-amino-etoxi]fenil]metil]-2,4 tiazolidinadiona (rosiglitazona) y sus formas polimorficas
|
|
MXPA06012130A
(es)
|
2004-04-20 |
2007-01-31 |
Transtech Pharma Inc |
Derivados de tiazol y pirimidina substituidos como moduladores del receptor de melanocortina.
|
|
JP2007537296A
(ja)
*
|
2004-05-14 |
2007-12-20 |
アボット・ラボラトリーズ |
治療薬としてのキナーゼ阻害薬
|
|
US7351833B2
(en)
|
2004-07-23 |
2008-04-01 |
Abbott Laboratories |
(1S,5S)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane benzenesulfonate
|
|
US7449486B2
(en)
|
2004-10-19 |
2008-11-11 |
Array Biopharma Inc. |
Mitotic kinesin inhibitors and methods of use thereof
|
|
US8436176B2
(en)
|
2004-12-30 |
2013-05-07 |
Medicis Pharmaceutical Corporation |
Process for preparing 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridin-4-amine
|
|
EA012211B1
(ru)
|
2005-01-07 |
2009-08-28 |
Пфайзер Продактс Инк. |
Гетероароматические соединения хинолинов и их применение в качестве ингибиторов pde10
|
|
MX2007009388A
(es)
|
2005-02-04 |
2007-09-25 |
Senomyx Inc |
Compuestos que comprenden porciones heteroarilo unidas y su uso como modificadores del sabor unami, saborizantes y mejoradores del sabor para composiciones comestibles.
|
|
AR056319A1
(es)
|
2005-04-22 |
2007-10-03 |
Kalypsys Inc |
Inhibidores de orto-terfinilo de p38 quinasa, composicion farmaceutica y compuestos intermedios
|
|
UA91546C2
(uk)
|
2005-05-03 |
2010-08-10 |
Бьорінгер Інгельхайм Інтернаціональ Гмбх |
КРИСТАЛІЧНА ФОРМА 1-ХЛОР-4-(β-D-ГЛЮКОПІРАНОЗ-1-ИЛ)-2-[4-((S)-ТЕТРАГІДРОФУРАН-3-ІЛОКСИ)-БЕНЗИЛ]-БЕНЗОЛУ, СПОСІБ ЇЇ ОДЕРЖАННЯ ТА ЇЇ ЗАСТОСУВАННЯ ПРИ ПРИГОТУВАННІ ЛІКАРСЬКИХ ЗАСОБІВ
|
|
MY152185A
(en)
|
2005-06-10 |
2014-08-29 |
Novartis Ag |
Modified release 1-[(3-hydroxy-adamant-1-ylamino)-acetyl]-pyrrolidine-2(s)-carbonitrile formulation
|
|
CA2617788A1
(en)
|
2005-08-04 |
2007-02-15 |
Apogee Biotechnology Corporation |
Sphingosine kinase inhibitors and methods of their use
|
|
JP5063600B2
(ja)
|
2005-08-29 |
2012-10-31 |
サノフイ−アベンテイス・ユー・エス・エルエルシー |
ピリダジノ［４，５−ｂ］インドール誘導体の新規な結晶形
|
|
KR20070085703A
(ko)
|
2005-09-13 |
2007-08-27 |
시코르, 인크. |
로큐로늄 브로마이드의 합성 방법
|
|
AU2006316079B2
(en)
|
2005-11-15 |
2012-03-29 |
Otsuka Pharmaceutical Co., Ltd. |
Oxazole compound and pharmaceutical composition
|
|
CN101341131A
(zh)
|
2005-12-23 |
2009-01-07 |
阿斯利康(瑞典)有限公司 |
作为gaba-b受体调节剂的咪唑
|
|
JP2009535394A
(ja)
|
2006-05-02 |
2009-10-01 |
ファイザー・プロダクツ・インク |
Ｐｄｅ１０阻害剤としての二環式ヘテロアリール化合物
|
|
US20080090834A1
(en)
|
2006-07-06 |
2008-04-17 |
Pfizer Inc |
Selective azole pde10a inhibitor compounds
|
|
CN101568331A
(zh)
|
2006-09-08 |
2009-10-28 |
奥尔制药有限公司 |
减少或缓解消化道炎症的方法
|
|
SG10201609581TA
(en)
|
2006-09-25 |
2016-12-29 |
Ptc Therapeutics Inc |
Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid
|
|
CA2663569A1
(en)
|
2006-09-28 |
2008-04-03 |
Merck & Co., Inc. |
Pharmaceutical compositions of hdac inhibitors and chelatable metal compounds, and metal-hdac inhibitor chelate complexes
|
|
US20090253918A1
(en)
|
2006-10-02 |
2009-10-08 |
Janssen Pharmaceuticals, N.V. |
Novel intermediate for glyt1 inhibitor
|
|
US7837978B2
(en)
|
2006-10-13 |
2010-11-23 |
Chevron U.S.A. Inc. |
Process for preparing aluminum-containing molecular sieve SSZ-26
|
|
US7786139B2
(en)
|
2006-11-21 |
2010-08-31 |
Omeros Corporation |
PDE10 inhibitors and related compositions and methods
|
|
EP2083819B1
(en)
*
|
2006-11-21 |
2017-02-22 |
Omeros Corporation |
Pde10 inhibitors and related compositions and methods
|
|
PE20081506A1
(es)
|
2006-12-12 |
2008-12-09 |
Infinity Discovery Inc |
Formulaciones de ansamicina
|
|
WO2009008906A2
(en)
|
2007-02-06 |
2009-01-15 |
The Trustees Of The University Of Pennsylvania |
Therapeutic compounds for blocking dna synthesis of pox viruses
|
|
WO2008143500A1
(en)
|
2007-05-22 |
2008-11-27 |
Ultimorphix Technologies B.V. |
Tenofovir disoproxil hemi-fumaric acid co-crystal
|
|
EP2017264A1
(de)
|
2007-07-16 |
2009-01-21 |
Bayer Cropscience Ag |
Substituierte Phenylpropargylverbindungen, Verfahren zu deren Herstellung und deren Verwendung als Herbizide und Pflanzenwachstumsregulatoren
|
|
WO2009049022A1
(en)
|
2007-10-10 |
2009-04-16 |
Ore Pharmaceuticals Inc. |
Method for treatment of pancreatitis
|
|
TW200944520A
(en)
|
2008-01-29 |
2009-11-01 |
Glaxo Group Ltd |
Spiro compounds as NPY Y5 receptor antagonists
|
|
WO2009143178A2
(en)
|
2008-05-20 |
2009-11-26 |
Omeros Corporation |
Pde10 inhibitors and related compositions and methods
|
|
TWI501965B
(zh)
|
2008-06-20 |
2015-10-01 |
Lundbeck & Co As H |
作為ｐｄｅ１０ａ酵素抑制劑之新穎苯基咪唑衍生物
|
|
CN102143752B
(zh)
*
|
2008-08-05 |
2014-12-10 |
奥默罗斯公司 |
Pde10抑制剂以及相关组合物和方法
|
|
NZ601967A
(en)
|
2010-03-12 |
2015-03-27 |
Omeros Corp |
Pde10 inhibitors and related compositions and methods
|
|
NZ716462A
(en)
*
|
2014-04-28 |
2017-11-24 |
Omeros Corp |
Optically active pde10 inhibitor
|